|
Press Releases |
|
 |
|
Monday, March 13, 2017 |
|
雅各臣公布收购康宁行70%权益 |
从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业-雅各臣科研制药有限公司(「雅各臣」或「集团」;股份代号:2633)今天公布收购康宁行集团(包括「康宁行有限公司」及其香港附属公司)的70%权益,总代价为56,000,000港元。 more info >> |
|
雅各臣公布收購康寧行70%權益 |
從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業-雅各臣科研製藥有限公司(「雅各臣」或「集團」;股份代號:2633)今天公佈收購康寧行集團(包括「康寧行有限公司」及其香港附屬公司)的70%權益,總代價為56,000,000港元。完成收購後,康寧行集團將成為雅各臣間接非全資附屬公司。 more info >> |
|
Jacobson Pharma Announces Acquisition of 70% Interest in Hong Ning Hong |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production more info >> |
|
Wednesday, January 18, 2017 |
|
雅各臣收购「十灵丹」、「十灵油」及「伤风克」建立具扩展性平台 |
从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业-雅各臣科研制药有限公司(「雅各臣」或「集团」;股份代号:2633)今天公布收购一系列家喻户晓的药品品牌,包括「十灵丹」、「十灵油」及「伤风克」。 more info >> |
|
雅各臣收購「十靈丹」、「十靈油」及「傷風克」建立具擴展性平台 |
從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業-雅各臣科研製藥有限公司(「雅各臣」或「集團」;股份代號:2633)今天公佈收購一系列家喻戶曉的藥品品牌,包括「十靈丹」、「十靈油」及「傷風克」。 more info >> |
|
Jacobson Pharma to Acquire Saplingtan, Shiling Oil & Col-gan Tablet; Creating an Expandable Proprietary Medicine Platform |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its acquisition of a family of popular household brands, namely, Saplingtan, Shiling Oil and Col-gan Tablet. more info >> |
|
Tuesday, December 13, 2016 |
|
雅各臣公布完成收购「何济公」之100%权益 |
从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业—雅各臣科研制药有限公司(「雅各臣」或「集团」;股份代号:2633)今天宣布完成收购目标集团(由「嘉伦药业有限公司」、「永生药业有限公司」及「香港何济公药厂有限公司」组成),该目标集团拥有传统居家品牌「何济公」之100%权益,总代价为568,000,000港元。 more info >> |
|
雅各臣公佈完成收購「何濟公」之100%權益 |
從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業—雅各臣科研製藥有限公司(「雅各臣」或「集團」;股份代號:2633)今天宣佈完成收購目標集團(由「嘉倫藥業有限公司」、「永生藥業有限公司」及「香港何濟公藥廠有限公司」組成),該目標集團擁有傳統居家品牌「何濟公」之100%權益,總代價為568,000,000港元。 more info >> |
|
Jacobson Pharma Announces Acquisition of 100% Interest in Ho Chai Kung Brand |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary Chinese medicines, today announces the acquisition of 100% interest in a Target Group (comprising "Karen Pharmaceutical Company Limited" more info >> |
|
Wednesday, November 23, 2016 |
|
雅各臣公布二零一六年中期业绩 |
从事非专利药及中成药研发、生产、市场推广及销售的领先企业,以及香港最大的非专利药公司─雅各臣科研制药有限公司(「雅各臣」或「公司」;股份代号:2633 )今天公布公司及附属公司(统称「集团」)截至二零一六年九月三十日止六个月(「报告期」)的未经审核中期业绩。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Buy International Homes at the Global Property Expo, Singapore
Jul 15, 2025 20:06 HKT/SGT
|
|
|
XDS Datacentres signs 15-year deal to host 10MW of AI workloads in Saudi's Desert Dragons facilities
Jul 15, 2025 19:41 HKT/SGT
|
|
|
U.S. Polo Assn. Celebrates Seventh Year Supporting the 2025 Outsourcing Inc. Royal Charity Polo Cup
Jul 15, 2025 19:00 HKT/SGT
|
|
|
Ocean One Seizing Business Opportunities with Main Board Listing Application
Jul 15, 2025 19:00 HKT/SGT
|
|
|
大洋環球申轉主板上市捉緊商機 迎中國恢復部分日本水產進口機遇
Jul 15, 2025 18:22 HKT/SGT
|
|
|
大洋环球申转主板上市捉紧商机 迎中国恢复部分日本水产进口机遇
Jul 15, 2025 18:10 HKT/SGT
|
|
|
雲頂新耀股價創階段新高 通用型現貨腫瘤治療性疫苗EVM14「中美雙報」再釋mRNA平台潛力
Jul 15, 2025 17:40 HKT/SGT
|
|
|
云顶新耀股价创阶段新高 通用型现货肿瘤治疗性疫苗EVM14"中美双报"再释mRNA平台潜力
Jul 15, 2025 17:34 HKT/SGT
|
|
|
耀啟新程!康哲藥業今日於新加坡交易所主板實現二次上市
Jul 15, 2025 17:05 HKT/SGT
|
|
|
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease
Jul 15, 2025 17:00: JST
|
|
|
耀启新程!康哲药业今日于新加坡交易所主板实现二次上市
Jul 15, 2025 16:53 HKT/SGT
|
|
|
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease
Jul 15, 2025 16:00 HKT/SGT
|
|
|
ONERHT Foundation Announces 8th edition of GAIL Forum which will focus on Green Leadership in ASEAN
Jul 15, 2025 13:00 HKT/SGT
|
|
|
PCG Collaborates with Big Boss Taxi and STAY BAR to Usher in a Cashless Era
Jul 15, 2025 12:30 HKT/SGT
|
|
|
交易寶攜手Big Boss Taxi與STAY BAR開啟無現金新時代
Jul 15, 2025 12:30 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|